[조직개발] 한미약품 co. Bio-tech R&D Unit

 1  [조직개발] 한미약품 co. Bio-tech R&D Unit-1
 2  [조직개발] 한미약품 co. Bio-tech R&D Unit-2
 3  [조직개발] 한미약품 co. Bio-tech R&D Unit-3
 4  [조직개발] 한미약품 co. Bio-tech R&D Unit-4
 5  [조직개발] 한미약품 co. Bio-tech R&D Unit-5
 6  [조직개발] 한미약품 co. Bio-tech R&D Unit-6
 7  [조직개발] 한미약품 co. Bio-tech R&D Unit-7
 8  [조직개발] 한미약품 co. Bio-tech R&D Unit-8
 9  [조직개발] 한미약품 co. Bio-tech R&D Unit-9
 10  [조직개발] 한미약품 co. Bio-tech R&D Unit-10
 11  [조직개발] 한미약품 co. Bio-tech R&D Unit-11
 12  [조직개발] 한미약품 co. Bio-tech R&D Unit-12
 13  [조직개발] 한미약품 co. Bio-tech R&D Unit-13
※ 미리보기 이미지는 최대 20페이지까지만 지원합니다.
  • 분야
  • 등록일
  • 페이지/형식
  • 구매가격
  • 적립금
자료 다운로드  네이버 로그인
소개글
[조직개발] 한미약품 co. Bio-tech R&D Unit에 대한 자료입니다.
목차
I.Introduction of Hanmi
II. Change
III. Vision of Hanmi
IV. Limitation of Korean pharmaceutical company
V. Two Strategies – First Generic Strategy & Original Strategy
VI. The rising industry – BIOTECHNOLOGY!
VII. Process of Bio-technology R&D unit
본문내용
I. Introduction of Hanmi
Hanmi is pharmaceutical company spearheading innovation in life science. Hanmi was established by Lim,Sung Gi in 1973 based on mottoes –“Human Respect” & “Creation of Value”, Hanmi has endless exerted all its power for precious human life. For the purpose of the progress of pharmaceutical industry and the supply of highly qualified medicines with the most advanced facilities according to KGMP. These efforts has made Hanmi one of the leading and promising pharmaceutical companies in Korea. So, Hanmi has showed continuous annual growth of 20%~30% since its establishment in 1973. And in 2003, its amount of total sales was nearly 243 billion won.
In 2000, all Korean pharmaceutical companies confronted radical change of their business environment. The change is ‘the separation of prescription and drug dispensing. Before the policy, the professional roles of Korea’s doctors and pharmacists overlapped under the past system. Pharmacists were allowed to write prescriptions while doctors were free to dispense medication to their patients.